| Literature DB >> 23145854 |
Rainer Wilcken1, Markus O Zimmermann, Andreas Lange, Andreas C Joerger, Frank M Boeckler.
Abstract
Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design. In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery. We summarize the theoretical background defining its strength and directionality, provide a systematic analysis of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization. In light of these data, we discuss the potential and limitations of exploiting halogen bonds for molecular recognition and rational drug design.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23145854 DOI: 10.1021/jm3012068
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446